"Given the unreported delays in expected release of trial results I would suggest that the next news will be in relation to company funding. I would like it to be a farm in. Which ever way it goes IVX will not go unfunded so I am not concerned by the cash position but I am concerned about the lack of reporting to shareholders about trial recruiting progress"
Perhaps I should have said curious rather than "concerned" Running a medical trial is far different to an oil explorer spudding a well. As has been said by others Invion has potential for a future so bright that we will have to wear shades. I am committed and will wait for the results to come when they do. I won't let the day traders effects on share price change my long view. I still stand by my opinion that the next news will be about funding.
IVX Price at posting:
9.0¢ Sentiment: LT Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)